RESUMEN
BACKGROUND: The aim of this study was to assess the efficacy of tigecycline in the treatment of infections due to carbapenemase-producing Klebsiella pneumoniae (CPKP) in critically ill patients. METHODS: A retrospective observational study was conducted in critically ill patients receiving different tigecycline doses for severe CPKP infections. We evaluated demographic data, localization and severity of infection, response to therapy, and mortality. RESULTS: Fifteen patients received tigecycline for 16 episodes of CPKP infection. The main infections were pneumonia (31%), urinary tract infection (31%), peritonitis (20%), catheter-related bacteraemia (12%), and meningitis (6%). Most infections were complicated with severe sepsis (44%), septic shock (12%), and/or bacteraemia (19%). The daily maintenance dose of tigecycline was 200 mg in 10 episodes and 100 mg in 6 episodes. The overall 30-day mortality rate was 25%. Univariate analysis showed that mortality was significantly associated (p < 0.01) with mean APACHE II and SOFA scores and the presence of immunosuppression, but not with the tigecycline dose. CONCLUSIONS: Tigecycline appears to be an effective therapy for severe infections due to CPKP in critically ill patients. Mortality is related to the severity of the underlying disease. We observed no benefit from a higher maintenance dose of tigecycline, although the number of patients included in the study was too small to draw any general conclusions in this regard.
Asunto(s)
Antibacterianos/uso terapéutico , Proteínas Bacterianas/biosíntesis , Infecciones por Klebsiella/tratamiento farmacológico , Klebsiella pneumoniae/efectos de los fármacos , Minociclina/análogos & derivados , beta-Lactamasas/biosíntesis , Adulto , Anciano , Antibacterianos/efectos adversos , Antibacterianos/farmacología , Enfermedad Crítica , Farmacorresistencia Bacteriana Múltiple , Femenino , Humanos , Infecciones por Klebsiella/microbiología , Klebsiella pneumoniae/enzimología , Klebsiella pneumoniae/aislamiento & purificación , Masculino , Persona de Mediana Edad , Minociclina/efectos adversos , Minociclina/farmacología , Minociclina/uso terapéutico , Estudios Retrospectivos , TigeciclinaRESUMEN
OBJECTIVE: To present our experience with the implementation of a donation protocol following controlled cardiac death (Maastricht type III donation). DESIGN: A retrospective descriptive and observational study was made. SETTING: Intensive Care Unit of a third-level university hospital. PATIENTS: Eight patients in an irreversible state, in which withdrawal of all life support had been agreed, were evaluated as potential donors. INTERVENTIONS: Application of the adopted protocol. VARIABLES OF INTEREST: Clinical data of donors, evaluation of a donation protocol following cardiac death, warm ischemia times, and short-term outcome of the recipients. RESULTS: Eight patients were evaluated. In one case donation was not possible because no cardiac arrest developed in the 120 minutes after extubation. The 7 remaining patients were effective kidney donors. Warm ischemia times were less than 23 minutes in all cases. Although 7 of the 14 recipients suffered delayed graft function, all of them achieved good renal function. CONCLUSION: Donation after cardiac death in patients in an overwhelming and irreversible state represents a potential source of donors not previously considered in this country. The prior development of a consensus-based protocol can help increase the number of organs in combination with those obtained after brain death. In our experience, the results of kidney transplants obtained from donors after cardiac death are good, and the success of these types of protocols could be extended to other organs such as the liver and lungs.
Asunto(s)
Muerte , Obtención de Tejidos y Órganos/clasificación , Obtención de Tejidos y Órganos/normas , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Guías de Práctica Clínica como Asunto , Estudios RetrospectivosAsunto(s)
Neumocéfalo/diagnóstico por imagen , Complicaciones Posoperatorias/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Anciano , Bradicardia/etiología , Trastornos de la Conciencia/etiología , Descompresión Quirúrgica , Drenaje , Urgencias Médicas , Hematoma Subdural/cirugía , Humanos , Masculino , Neumocéfalo/cirugía , Complicaciones Posoperatorias/cirugíaRESUMEN
No disponible
Asunto(s)
Humanos , Femenino , Adulto , Foramen Oval Permeable/cirugía , Rotura Cardíaca/etiología , Dispositivos de Cierre Vascular/efectos adversos , Complicaciones Posoperatorias , PericardiocentesisRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Adolescente , Hemorragia Cerebral/diagnóstico por imagen , Hemorragia Cerebral/patología , Tomografía Computarizada por Rayos XRESUMEN
OBJETIVO: Presentar la experiencia inicial con la implantación de un programa de donación tras la muerte cardiaca controlada en donantes tipo III de Maastricht. DISEÑO: Estudio retrospectivo, observacional y descriptivo. Ámbito: Unidad de cuidados intensivos de un hospital universitario terciario. PARTICIPANTES: Se evalúan 8 pacientes con enfermedad irreversible en los que se aplica la limitación de las técnicas de soporte vital y se consideran como potenciales donantes de órganos. INTERVENCIONES: Aplicación del protocolo presentado. Variables de interés: Características clínicas de los donantes, tipo de protocolo de donación aplicado, tiempos de isquemia caliente manejados y evolución a corto plazo de los receptores. RESULTADOS: Se incluyeron 8 pacientes. En uno de ellos se suspendió la donación al no fallecer en los 120min siguientes a la extubación terminal. Los 7 restantes fueron donantes renales efectivos. Los tiempos de isquemia caliente estuvieron siempre por debajo de los 23min. Los 14 receptores evolucionaron favorablemente; 7 de ellos presentaron retraso en la función del injerto pero en todos mejoró la función renal. CONCLUSIÓN: La donación tras la muerte cardiaca controlada en pacientes con enfermedad irreversible y catastrófica es una potencial fuente de donantes no considerada en nuestro país hasta el momento actual. Un programa previamente consensuado puede suponer un incremento en el número de órganos a los ya proporcionados por medio de la donación tras la muerte encefálica. Los resultados del trasplante renal en nuestra experiencia han sido buenos y el éxito de este tipo de programas podría extenderse al trasplante hepático y pulmonar
OBJECTIVE: To present our experience with the implementation of a donation protocol following controlled cardiac death (Maastricht type III donation). DESIGN: A retrospective descriptive and observational study was made. SETTING: Intensive Care Unit of a third-level university hospital. PATIENTS: Eight patients in an irreversible state, in which withdrawal of all life support had been agreed, were evaluated as potential donors. INTERVENTIONS: Application of the adopted protocol. Variables of interest: Clinical data of donors, evaluation of a donation protocol following cardiac death, warm ischemia times, and short-term outcome of the recipients. RESULTS: Eight patients were evaluated. In one case donation was not possible because no cardiac arrest developed in the 120minutes after extubation. The 7 remaining patients were effective kidney donors. Warm ischemia times were less than 23minutes in all cases. Although 7 of the 14 recipients suffered delayed graft function, all of them achieved good renal function. CONCLUSION: Donation after cardiac death in patients in an overwhelming and irreversible state represents a potential source of donors not previously considered in this country. The prior development of a consensus-based protocol can help increase the number of organs in combination with those obtained after brain death. In our experience, the results of kidney transplants obtained from donors after cardiac death are good, and the success of these types of protocols could be extended to other organs such as the liver and lungs
Asunto(s)
Humanos , Obtención de Tejidos y Órganos/normas , Muerte Encefálica , Extubación Traqueal/normas , Árboles de Decisión , Protocolos Clínicos , Estudios Retrospectivos , Unidades de Cuidados Intensivos , /normas , Donantes de TejidosRESUMEN
No disponible